MST CONTINUS Prolonged-release tablet Ref.[27738] Active ingredients: Morphine

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2020 Publisher: Napp Pharmaceuticals Limited, Cambridge Science Park, Milton Road, Cambridge CB4 0GW

Product name and form

MST CONTINUS 5 mg, 10 mg, 15 mg, 30 mg, 60 mg, 100 mg, 200 mg prolonged release tablets.

Pharmaceutical Form
Prolonged-release tablet. Film coated, biconvex tablet marked with the NAPP logo on one side and the strength of the tablet on the other. MST CONTINUS tablets 5 mg are white MST CONTINUS tablets 10 mg are golden brown. MST CONTINUS tablets 15 mg are green. MST CONTINUS tablets 30 mg are purple. MST CONTINUS tablets 60 mg are orange. MST CONTINUS tablets 100 mg are grey. MST CONTINUS tablets 200 mg are teal green.

Qualitative and quantitative composition

Each tablet contains Morphine Sulfate 5 mg, 10 mg, 15 mg, 30 mg, 60 mg, 100 mg, 200 mg.

Excipients with known effect:

5 mg tablet also contains lactose anhydrous 95 mg.
10 mg tablet also contains lactose anhydrous 90 mg.
15 mg tablet also contains lactose anhydrous 85 mg.
30 mg tablet also contains lactose anhydrous 70 mg.
60 mg tablet also contains lactose anhydrous 40 mg.
30 mg and 60 mg tablets also contain a small amount (<1 mg) sunset yellow (E110).

For the full list of excipients see section 6.1.

Active Ingredient	Description
Morphine	Morphine is a narcotic analgesic obtained from opium. Morphine acts as an agonist at opiate receptors in the CNS particularly Mu and to a lesser extent Kappa receptors. Mu receptors are thought to mediate supraspinal analgesia, respiratory depression and euphoria, and Kappa receptors, spinal analgesia, miosis and sedation.

List of Excipients
Tablet core: Lactose anhydrous Hydroxyethylcellulose Purified water Cetostearyl alcohol Magnesium stearate Purified talc Film coat: 5 mg – Opadry Y-1-7000 white containing E171, Purified water 10 mg – Polyvinyl alcohol, Macrogol 3350, talc, E171, E172 15 mg – Opadry 02B21169 (containing E464, E171, Macrogol 400, E104, E133, E132, E172), Purified Water 30 mg – Opadry OY-6708 violet, Purified Water 60 mg – Opadry OY-3508 orange, Purified Water 100 mg – Opadry OY 8215 grey, Purified Water 200 mg – Opadry 06B21168 (containing E464, E171, E133, E104, Macrogol 400), Macrogol 400, Purified Water

Pack sizes and marketing

Aluminium foil-backed PVdC/PVC blister packs. Pack size 60 tablets.

Marketing authorization holder

Napp Pharmaceuticals Limited, Cambridge Science Park, Milton Road, Cambridge CB4 0GW

Marketing authorization dates and numbers

PL 16950/0035, PL 16950/0036, PL 16950/0037, PL 16950/0038, PL 16950/0039, PL 16950/0040, PL 16950/0041

25/02/2009

Drugs

Drug	Countries
MST CONTINUS	Cyprus, Estonia, Croatia, Ireland, Malta, Poland, United Kingdom, South Africa

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.